期刊文献+

5例病理确诊的肺毛霉菌病临床分析 被引量:6

Clinical analysis of 5 patients with pathologically diagnosed pulmonary mucormycosis
下载PDF
导出
摘要 目的探讨肺毛霉菌病的临床特征。方法经病理确诊的5例肺毛霉菌病患者的临床资料进行分析。结果 4例患者分别合并糖尿病、支气管扩张、肺结核等基础疾病,咳嗽(3/4)、咳痰(3/4),发热(3/4),咯血(3/4)是常见的临床症状,胸部影像学表现为多发斑片状病灶3例,多发空洞病灶1例,单一团块病灶1例,病灶伴有空洞形成4例。治疗结果为痊愈1例,好转2例,死亡1例,无法判断1例。结论肺毛霉菌病临床罕见,临床表现与影像学特征缺乏特异性,患者多并存基础疾病,对具有高危因素的患者早期进行病理组织学检查对改善肺毛霉菌病患者预后具有重要价值。 Objective To investigate the clinical features of pulmonary mucormycosis. Methods Retrospective analysis was performed on the clinical data in 5 patients with pathologically diagnosed pulmonary mucormycosis in General Hospital of Chinese People's Liberation Army from January 1991 to December 2010. Results g patients suffered from diabetes, bronehiectasis, tuberculosis and other underlying diseases. Cough (3/4), expectoration (3/4), fever (3/4) and hemoptysis (3/4) were the most common symptoms. Chest imaging showed multiple patchy lesions in 3 cases, multiple eavitary lesions in 1 case, a single mass lesion in 1 case, and lesions associat- ed with cavity formation in g cases. 1 patient was cured, 2 patients were improved, 1 patient died and the outcome could not be judged in 1 patient. Conclusions Pulmonary mucormycosis is a rare disease and the clinical manifestation and image feature were not specific. At- tention should be paid to the patients with underlying diseases and high risk factors. Histopathological examination was necessary for the early diagnosis of pulmonary mucormycosis and may improve survival.
出处 《临床肺科杂志》 2012年第3期418-420,共3页 Journal of Clinical Pulmonary Medicine
关键词 肺真菌感染 毛霉菌病 治疗 pulmonary fungal infection mucormycosis therapy
  • 相关文献

参考文献10

  • 1无.肺真菌病诊断和治疗专家共识[J].中华结核和呼吸杂志,2007,30(11):821-834. 被引量:605
  • 2Yano S,Minami J,Nishiwaki K,et al.Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies:analysis of eight patients[J].Int J Hematol,2011,93(3):344-350.
  • 3Spellberg B,Edwards J Jr,Ibrahim A.Novel perspectives on mucormycosis:pathophysiology,presentation,and management[J].Clin Microbiol Rev,2005,18(3):556-569.
  • 4Quan C,Spellberg B.Mucormycosis,pseudallescheriasis,and other uncommon mold infections[J].Proc Am Thorac Soc,2010,7(3):210-215.
  • 5孙莹,孙文青,赵婷婷,周明香.肺结核合并肺毛霉菌感染的临床分析[J].临床肺科杂志,2008,13(11):1440-1441. 被引量:9
  • 6Roden MM,Zaoutis TE,Buchanan WL,et al.Epidemiology and outcome of zygomycosis:a review of 929 reported cases[J].Clin Infect Dis,2005,41(5):634-653.
  • 7Kontoyiannis DP,Lewis RE.Invasive zygomycosis:update on pathogenesis,clinical manifestations,and management[J].Infect Dis Clin North Am,2006,20(3):581-607.
  • 8Chamilos G,Lewis RE,Kontoyiannis DP.Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis[J].Clin Infect Dis,2008,47(4):503-509.
  • 9van Burik JA,Hare RS,Solomon HF,et al.Posaconazole is effective as salvage therapy in zygomycosis:a retrospective summary of 91cases[J].Clin Infect Dis,2006,42(7):e61-65.
  • 10Gleissner B,Schilling A,Anagnostopolous I,et al.Improved outcome of zygomycosis in patients with hematological diseases[J] ?Leuk Lymphoma,2004,45(7):1351-1360.

二级参考文献11

共引文献612

同被引文献25

引证文献6

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部